Once-Weekly Ribupatide for Weight Loss in Adults in China With Overweight or Obesity: The GEMINI-1 Randomized Clinical Trial
Year: 2026
Type: article
Source: JAMA
Authors: Lin Zhao, Ying Chen, Zhifeng Cheng, Dan Zhu, Qifu Li, Hanqing Cai, Yuan Hui, Qi Wang, Junfeng Han, Zongyou Cheng, Guiping Li, Shumei Zhong, Jinyang Wang, Lianwei Wang, Chao Meng, Shu Li, Hongye Su, Yi Xu, Meifang Zeng, Yue Zuo, Lei Zhang, Wenhua Wei, Lihao Wang, Yike Wang, Minzhi Lv, Hong Chen, Xiaoying Li
Institutions: Fudan University, Zhongshan Hospital, Harbin Medical University, Fourth Affiliated Hospital of Harbin Medical University, Peking University Third Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Jilin University, Second Affiliated Hospital of Jilin University, The First People’s Hospital of Lianyungang, Lu'an First People's Hospital, Tongji University, Jiangxi Provincial People's Hospital, Guangzhou Medical University, Ganzhou People's Hospital, Gansu Provincial Hospital, Zhumadian Central Hospital, Shandong First Medical University, Huizhou Central People's Hospital, Guangxi Medical University, Affiliated Hospital of Guizhou Medical University, Jiangsu Hengrui Medicine (China)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7233594866
